Target
Neurotensin receptor type 2
Ligand
BDBM85844
Substrate
n/a
Ki
17±n/a nM
Comments
PDSP_3752
Citation
 Pettibone, DJHess, JFHey, PJJacobson, MALeviten, MLis, EVMallorga, PJPascarella, DMSnyder, MAWilliams, JBZeng, Z The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. J Pharmacol Exp Ther 300:305-13 (2002) [PubMed]  Article 
Target
Name:
Neurotensin receptor type 2
Synonyms:
NTR2_MOUSE | Neurotensin 2 | Neurotensin receptor type 2 | Ntsr2
Type:
Enzyme Catalytic Domain
Mol. Mass.:
46391.18
Organism:
MOUSE
Description:
P70310
Residue:
416
Sequence:
METSSLWPPRPSPSAGLSLEARLGVDTRLWAKVLFTALYSLIFALGTAGNALSVHVVLKARAGRPGRLRYHVLSLALSALLLLLISVPMELYNFVWSHYPWVFGDLGCRGYYFVRELCAYATVLSVASLSAERCLAVCQPLRARRLLTPRRTRRLLSLVWVASLGLALPMAVIMGQKHEMERADGEPEPASRVCTVLVSRATLQVFIQVNVLVSFVLPLALTAFLNGITVNHLVALYSQVPSASAQVNSIPSRLELLSEEGLLGFITWRKTLSLGVQASLVRHKDASQIRSLQHSAQVLRAIVAVYVICWLPYHARRLMYCYIPDDGWTDELYDFYHYFYMVTNTLFYVSSAVTPVLYNAVSSSFRKLFLESLSSLCGEQRSVVPLPQEAPESTTSTYSFRLWGSPRNPSLGEIQV
  
Inhibitor
Name:
BDBM85844
Synonyms:
CAS_54385 | Levocabastine | NSC_54385
Type:
Small organic molecule
Emp. Form.:
C26H29FN2O2
Mol. Mass.:
420.5191
SMILES:
CC1CN(CCC1(C(O)=O)c1ccccc1)C1CCC(CC1)(C#N)c1ccc(F)cc1 |(1.11,-6.21,;-.22,-6.98,;-.22,-8.52,;-1.56,-9.29,;-2.89,-8.52,;-2.89,-6.98,;-1.56,-6.21,;-.84,-4.85,;-.73,-3.31,;.7,-4.8,;-2.28,-4.85,;-3.82,-4.8,;-4.54,-3.44,;-3.73,-2.13,;-2.19,-2.18,;-1.47,-3.54,;-1.56,-10.83,;-2.89,-11.6,;-2.89,-13.14,;-1.56,-13.91,;-.22,-13.14,;-.22,-11.6,;-2.28,-15.27,;-3,-16.63,;-.84,-15.27,;.7,-15.32,;1.43,-16.68,;.61,-17.99,;1.33,-19.35,;-.93,-17.93,;-1.65,-16.57,)|
Structure:
Search PDB for entries with ligand similarity: